HTG Molecular Diagnostics

About HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc., based in Tucson, Arizona, is a biotechnology company specializing in precision medicine. The company leverages its proprietary RNA platform technologies to advance translational research, clinical diagnostics, and targeted therapeutics. HTG's technology focuses on transcriptome-wide profiling, which involves analyzing the complete set of RNA transcripts produced by the genome. This allows for more effective and efficient development of life science tools and diagnostics, ultimately accelerating drug discovery and improving patient outcomes.

HTG serves a diverse range of clients, including biopharmaceutical companies, academic research institutions, contract research organizations (CROs), and government agencies. The company operates in the global biotechnology and pharmaceutical markets, where there is a growing demand for innovative diagnostic tools and personalized medicine solutions.

HTG's business model revolves around the development and commercialization of its RNA-based products and services. The company generates revenue through the sale of its proprietary HTG EdgeSeq systems and related consumables, as well as through service contracts and collaborative agreements with biopharma partners. Additionally, HTG offers its VERI/O laboratory services, which provide clients with comprehensive RNA profiling and data analysis.

By focusing on precision medicine, HTG aims to transform the way diseases are diagnosed and treated, ultimately leading to better patient outcomes. The company's commitment to innovation and collaboration with industry leaders positions it as a key player in the biotechnology sector.